Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Genflow Biosci (GENF) Share Price

Price 0.80p on 25-07-2025 at 18:50:05
Change -0.065p -7.88%
Buy 0.85p
Sell 0.75p
Last Trade: Sell 680.00 at 0.76p
Day's Volume: 6,982,306
Last Close: 0.76p
Open: 0.825p
ISIN: GB00BP2C3V08
Day's Range 0.75p - 0.80p
52wk Range: 0.575p - 2.35p
Market Capitalisation: £3.45m
VWAP: 0.803248p
Shares in Issue: 453.55m

Genflow Biosci (GENF) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 680 0.76p Uncrossing Trade
16:35:30 - 25-Jul-25
Sell* 68,815 0.793p Ordinary
16:24:43 - 25-Jul-25
Buy* 150,000 0.82p Ordinary
16:10:27 - 25-Jul-25
Buy* 53,154 0.82p Ordinary
15:15:17 - 25-Jul-25
Sell* 85 0.792p Ordinary
15:05:17 - 25-Jul-25
Sell* 250,000 0.792p Ordinary
14:58:05 - 25-Jul-25
Buy* 1,170 0.85p Ordinary
14:51:05 - 25-Jul-25
Sell* 533,334 0.792p Ordinary
14:49:08 - 25-Jul-25
Sell* 118,000 0.75p Uncrossing Trade
14:00:21 - 25-Jul-25
Sell* 50,000 0.7889p Ordinary
13:48:21 - 25-Jul-25
See more Genflow Biosci trades

Genflow Biosci (GENF) Share Price History

Time period:
to
Date Open High Low Close Volume
25th Jul 2025 (Fri) 0.825 0.80 0.75 0.76 6,982,306
24th Jul 2025 (Thu) 0.85 1.00 0.825 0.825 20,179,184
23rd Jul 2025 (Wed) 0.80 0.86 0.80 0.80 9,262,589
22nd Jul 2025 (Tue) 0.65 0.80 0.775 0.80 43,048,393
21st Jul 2025 (Mon) 0.70 0.70 0.65 0.65 8,137,059
18th Jul 2025 (Fri) 0.60 0.70 0.60 0.70 34,629,115
17th Jul 2025 (Thu) 0.70 0.71 0.575 0.71 26,269,289
16th Jul 2025 (Wed) 0.675 0.675 0.65 0.666 2,218,997
15th Jul 2025 (Tue) 0.70 0.70 0.675 0.675 8,079,024
14th Jul 2025 (Mon) 0.70 0.71 0.70 0.70 5,232,329
11th Jul 2025 (Fri) 0.675 0.70 0.675 0.70 7,138,186
10th Jul 2025 (Thu) 0.675 0.70 0.675 0.70 6,311,919
9th Jul 2025 (Wed) 0.75 0.75 0.675 0.675 17,077,690
8th Jul 2025 (Tue) 0.80 0.75 0.75 0.75 19,590,698
7th Jul 2025 (Mon) 0.675 0.80 0.675 0.80 53,389,981
4th Jul 2025 (Fri) 0.725 0.725 0.675 0.675 7,535,624
3rd Jul 2025 (Thu) 0.725 0.75 0.725 0.725 1,114,669
2nd Jul 2025 (Wed) 0.725 0.725 0.725 0.725 124,713
1st Jul 2025 (Tue) 0.725 0.725 0.725 0.725 507,372
30th Jun 2025 (Mon) 0.725 0.725 0.725 0.725 1,280,754
27th Jun 2025 (Fri) 0.725 0.725 0.725 0.725 179,801
26th Jun 2025 (Thu) 0.725 0.725 0.725 0.725 558,327
See more Genflow Biosci price history

Genflow Biosci (GENF) Regulatory News

Date Source Headline
24th Jul 2025 7:00 am RNS-R Clinical Readiness Acceleration
17th Jul 2025 7:00 am RNS Genflow Confirms Progression of Grant
17th Jun 2025 7:00 am RNS-R Corporate Update
12th Jun 2025 10:16 am RNS Result of AGM
30th May 2025 3:20 pm RNS Total Voting Rights
28th May 2025 7:00 am RNS-R Genflow Signs Master Services Agreement
22nd May 2025 10:51 am RNS AGM Notice
15th May 2025 7:00 am RNS-R Key SIRT6 Patent Application
12th May 2025 10:50 am RNS Holding(s) in Company
9th May 2025 7:00 am RNS Share Subscription, Director's Dealing and Update
See more Genflow Biosci regulatory news

Genflow Biosci (GENF) Share News

EARNINGS AND TRADING: Ondine widens loss as research expenses rise

15th May 2025 14:30

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More

IN BRIEF: Genflow Biosciences says investment a vote of confidence

9th May 2025 18:42

Genflow Biosciences PLC - London-based biotechnology firm, which has research facilities in Belgium - raises GBP500,000 via an allotment to Chief Executive Eric Leire of 62.5 million shares at 0.8 pence each. The net proceeds will be used to advance a proof-of-concept trial evaluating the safety and efficacy of its therapeutic candidate in aged dogs, potentially being also a key translational model for age-related conditions in humans. On allotment, Leire agrees to sell these shares at the same price to an already identified purchaser. Leire says: "This investment, without applying any discount, is a strong vote of confidence in our science." He adds: "With this support, we are well-positioned to accelerate our research and bring us closer to delivering impactful solutions to patients." Read More

IN BRIEF: Genflow launches new ophthalmology development programme

10th Apr 2025 14:24

Genflow Biosciences PLC - London-based biotechnology firm, which has research facilities in Belgium - Launches new ophthalmology development programme, focused on advancing a novel gene therapy via its proprietary gene technology. The therapy will use a specially designed non-viral vector engineered for precise delivery of Genflow's SIRT6 to the eye. It is designed to counter ocular problems including several pathologies of the cornea and glaucoma. Read More

Genflow Biosciences enters 2025 with confidence in research progress

6th Jan 2025 14:28

(Alliance News) - Genflow Biosciences PLC on Monday saw shares climb after reporting "significant strides" in its 2024 research programmes. Read More

Genflow Biosciences secures EUR4 million for liver disease treatment

22nd Oct 2024 11:49

(Alliance News) - Genflow Biosciences PLC on Tuesday said it has secured EUR4 million in funding from the Wallonia region in Belgium, to support its gene therapy development work. Read More

See more Genflow Biosci news
FTSE 100 Latest
Value9,120.31
Change-18.06

Login to your account

Forgot Password?

Not Registered